Stock listing
Symbio Pharmaceuticals Limited
Selected listing: SYMQY · OTC · USD · US
Symbio Pharmaceuticals Limited (OTC:SYMQY), Health Technology. Latest release Aug 10, 2026: Summary of Consolidated Financial Statements for the Six Months…
- Ticker
- OTC:SYMQY
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Symbio Pharmaceuticals Limited
The company focuses on developing innovative pharmaceutical solutions. Its strategic initiatives aim to address unmet medical needs and enhance patient care.
Latest news from Symbio Pharmaceuticals Limited
Summary of Consolidated Financial Statements for the Six Months ended June 30, 2026 [Japanese GAAP]
August 10, 2026
SymBio Pharmaceuticals : Summary of Financial Statements for the First Six Months of Fiscal Year Ending December 31, 2022 (Consolidated)
August 4, 2022
SymBio Pharmaceuticals : Revision to Earnings Forecast for FY 2022
August 4, 2022
Research Symbio Pharmaceuticals Limited
Symbio Pharmaceuticals Limited company profile
View the public company page for Symbio Pharmaceuticals Limited on 6ix.
Symbio Pharmaceuticals Limited news
Read company news and market updates connected to Symbio Pharmaceuticals Limited.
Symbio Pharmaceuticals Limited investor events
Find investor webinars, events, and replay context for Symbio Pharmaceuticals Limited.